Bile Acids Activated Receptors in Inflammatory Bowel Disease
Open accessThe DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
Once known exclusively for their role in nutrients absorption, bile acids have emerged as signaling molecules, generated from cholesterol breakdown, acting on several immune cells by activating a variety of receptors including the G protein-coupled bile acid receptor 1 (GPABR1 or TGR5), the Farnesoid-X-receptor (FXR) and, as recently discovered, the retinoid-related orphan receptors (ROR)γt. GPBAR1, FXR, and RORγt are highly expressed in cells of the innate and adaptive immune system (i.e., dendritic cells (DCs), macrophages, innate lymphoid 3 cells (ILC3s), and T helper 17 (Th17) lymphocytes) and plays an important role in regulating intestinal and liver immunity, highlighting a role for various bile acid species in regulating immune responses to intestinal microbial antigens. While primary bile acids are generated from the cholesterol breakdown secondary bile acids, the GPBAR1 ligands, and oxo-bile acids derivatives, the RORγt ligands, are generated by the intestinal microbiota, highlighting the potential of these bile acids in mediating the chemical communication between the intestinal microbiota and the host. Changes in intestinal microbiota, dysbiosis, alter the composition of the bile acid pool, promoting the activation of the immune system and development of chronic inflammation. In this review, we focus on the molecular mechanisms by which an altered bile acid signaling promotes intestinal inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“BA metabolism is defective in patients with IBD, as indicated by increased levels of primary BAs (PBAs) and/or their conjugated forms, accompanied by decreased levels of second BAs (SBAs) (Lavelle and Sokol, 2020; Biagioli et al., 2021; Gallagher et al., 2021).”
From Bacteroides dorei BDX-01 alleviates DSS-induced experimental colitis in mice by regulating intestinal bile salt hydrolase activity and the FXR-NLRP3 signaling pathway (2023) · cites this paper as Biagioli et al., 2021
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
Gevers, D., Kugathasan, S., Denson, L. A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., Schwager, E., Knights, D., Song, S. J., Yassour, M., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.005 · Cited by 3,220
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Lloyd-Price, J., Arze, C., Ananthakrishnan, A. N., Schirmer, M., Avila-Pacheco, J., Poon, T. W., Andrews, E., Ajami, N. J., Bonham, K. S., Brislawn, C. J., et al. (2019) · Nature · doi:10.1038/s41586-019-1237-9 · Cited by 3,143
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069 · cited 1×
“The large majority of these deconjugated primary bile acids and secondary bile acids that reach the terminal ileum are reabsorbed by the intestinal epithelial cells (IEC) and transported back to the liver through the portal vein, completing a cycle in the “enterohepatic circulation” [11,20,21].”
BackgroundGut microbiota-derived metabolites as key actors in inflammatory bowel disease
Lavelle, A., & Sokol, H. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0258-z · Cited by 2,015
Cited by
Gut-Microbiota-Derived Metabolites Maintain Gut and Systemic Immune Homeostasis
Wang, J., Zhu, N., Su, X., Gao, Y., & Yang, R. (2023) · Cells · doi:10.3390/cells12050793 · Cited by 588
Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity
Su, X., Gao, Y., & Yang, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1127743 · Cited by 159
The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease
Thomas, J. P., Modos, D., Rushbrook, S. M., Powell, N., & Korcsmaros, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.829525 · Cited by 156
Bile acids and their receptors in regulation of gut health and diseases
Lin, S., Wang, S., Wang, P., Tang, C., Wang, Z., Chen, L., Luo, G., Chen, H., Liu, Y., Feng, B., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101210 · Cited by 131
Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development
Li, T., & Chiang, J. Y. L. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.000978 · Cited by 90
Zheng, C., Wang, L., Zou, T., Lian, S., Luo, J., Lu, Y., Hao, H., Xu, Y., Xiang, Y., Zhang, X., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2023.12.024 · Cited by 77
Fan, Y., Xu, C., Xie, L., Wang, Y., Zhu, S., An, J., Li, Y., Tian, Z., Yan, Y., Yu, S., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.956528 · Cited by 56
“In addition, intestinal FXR activation induced transcription of genes involved in intestinal protection to prevent bacterial invasion and Frontiers in Cellular and Infection Microbiology 14 epithelial damage (Mosińska et al., 2018; Biagioli et al., 2021).”
BackgroundRegulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease
Li, L., Liu, T., Gu, Y., Wang, X., Xie, R., Sun, Y., Wang, B., & Cao, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.974305 · Cited by 57
Biagioli, M., Giorgio, C. D., Massa, C., Marchianò, S., Bellini, R., Bordoni, M., Urbani, G., Roselli, R., Lachi, G., Morretta, E., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117731 · Cited by 57
Self-citationFarnesoid X Receptor Agonists: A Promising Therapeutic Strategy for Gastrointestinal Diseases
Almeqdadi, M., & Gordon, F. D. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.09.013 · Cited by 55
Li, G., Xiong, Y., Li, Z., Yu, Q., Li, S., Xie, J., Zeng, S., Yu, D., Yang, Y., & Yu, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1710733 · Cited by 67
The role of intestinal microbiota and metabolites in intestinal inflammation
Ma, W., Huang, Z., Liu, K., Li, D., Mo, T., & Liu, Q. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127838 · Cited by 47
Núñez‐Sánchez, M. Á., Melgar, S., O'DONOGHUE, K., Martínez‐Sánchez, M. A., Fernández-Ruiz, V. E., Ferrer‐Gómez, M., Ruiz‐Alcaraz, A. J., & Ramos‐Molina, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158361 · Cited by 42
“There is a growing body of evidence suggesting that BA signaling through BA receptors (BARs), including farnesoid X receptor (FXR), a master regulator of BA synthesis [84], Takeda-G-protein-receptor-5 (TGR5) [85], and the vitamin D receptor (VDR) [86], can influence immune processes [87].”
BackgroundSun, X., Chen, Z., Yu, L., Zeng, W., Sun, B., Fan, H., & Bai, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1205323 · Cited by 33
“BA metabolism is defective in patients with IBD, as indicated by increased levels of primary BAs (PBAs) and/or their conjugated forms, accompanied by decreased levels of second BAs (SBAs) (Lavelle and Sokol, 2020; Biagioli et al., 2021; Gallagher et al., 2021).”
BackgroundLiu, R., Wang, J., Liu, Y., Gao, Y., & Yang, R. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217115 · Cited by 34
Michaels, M., & Madsen, K. L. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2022.11.001 · Cited by 36
Ahmad, F., Saha, P., Singh, V., Wahid, M., Mandal, R. K., Mishra, B. N., Fagoonee, S., & Haque, S. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.135320 · Cited by 33
Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease
Long, X.-Q., Liu, M., Liu, Z.-H., Xia, L.-Z., Lu, S.-P., Xu, X.-P., & Wu, M. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i27.4252 · Cited by 30
Paepe, E. D., Plekhova, V., Vangeenderhuysen, P., Baeck, N., Bullens, D. M. A., Claeys, T., Graeve, M. D., Kamoen, K., Notebaert, A., de Wiele, T. V., et al. (2024) · Allergy · doi:10.1111/all.16005 · Cited by 26
“45,46 BALB/c mice undergoing sensitization also exhibited higher levels of tryptophan metabolites and a higher (xanthurenate + 3-hydroxykynurenine)/ tryptophan ratio (Figure 4 ).”
BackgroundAtopic dermatitis and food allergy: More than sensitization
Davis, K. L., Claudio-Etienne, E., & Frischmeyer‐Guerrerio, P. A. (2024) · Mucosal Immunology · doi:10.1016/j.mucimm.2024.06.005 · Cited by 33
Urbani, G., Rondini, E., Distrutti, E., Marchianò, S., Biagioli, M., & Fiorucci, S. (2025) · Cells · doi:10.3390/cells14080595 · Cited by 28
“…and GPBAR1 exert immunoregulatory effects [203,213,223] in the liver, intestine [224] and cardiovascular system [225] (Figure 3). to these metabolic e ff ects, both FXR and GPBAR1 exert immunoregulatory e ff ects [203,213,223] in the liver, intestine [224] and cardiovascular system [225] (Figure 3).”
Self-citationFiorucci, S., Urbani, G., Giorgio, C. D., Biagioli, M., & Distrutti, E. (2024) · Cells · doi:10.3390/cells13191650 · Cited by 26
“…secondary bile acids, including 3-oxo-DCA and Iso-Allo-LCA function as inverse agonists of ROR γ t, a transcription factor involved in the regulation of immune responses, particularly through its role in the differ-Cells entiation of T h 17 cells and the production of pro-inflammatory [101–103].”
BackgroundSelf-citationLin, Q., Huang, W.-W., Shen, W., Deng, X., Tang, Z., Chen, Z., Zhao, W., & Fan, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.889646 · Cited by 25
Yi, Y.-L., Li, Y., Guo, S., Yan, H., Ma, X.-F., Tao, W., Shang, E., Niu, Y., Qian, D., & Duan, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.847828 · Cited by 20
Biagioli, M., Marchianò, S., Roselli, R., Giorgio, C. D., Bellini, R., Bordoni, M., Distrutti, E., Catalanotti, B., Zampella, A., Graziosi, L., et al. (2022) · Cells · doi:10.3390/cells11071187 · Cited by 22
“Because we have previously shown that Gpbar1 gene ablation promotes colon inflammation [16,21,23], we examined the expression of biomarkers of colon inflammation in the two strains and found that mice harboring a disrupted Gpbar1 exhibit a robust increase in Tnf-α, IL-1β and Il-6 (Figure 3G–I) along with a marked incr…”
BackgroundSelf-citationBile acid‐activated receptors in innate and adaptive immunity: targeted drugs and biological agents
Cheung, K. C. P., Ma, J., Loiola, R. A., Chen, X., & Jia, W. P. (2023) · European Journal of Immunology · doi:10.1002/eji.202250299 · Cited by 24
Buchynskyi, M., Kamyshna, I. I., Oksenych, V., Zavidniuk, N. H., & Kamyshnyi, O. (2023) · Viruses · doi:10.3390/v15051072 · Cited by 18
“The activation of both receptors occurs at relatively low concentrations of bile acids [151].”
BackgroundBile acids and bile acid activated receptors in the treatment of Covid-19
Fiorucci, S., Urbani, G., Biagioli, M., Sepe, V., Distrutti, E., & Zampella, A. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115983 · Cited by 18
Self-citationAn intestinal-targeting near-infrared probe for imaging nitroreductase in inflammatory bowel disease
Li, T., Gu, Q.-S., Chao, J., Liu, T., Mao, G., Li, Y., & Li, C. (2023) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2023.135181 · Cited by 21
Zheng, L. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i30.10823 · Cited by 17
Qin, Z., Li, M., Cheng, J., Huang, Z., Ai, G., Qu, C. F., Xie, Y., Li, Y., Liao, H., Xie, J., et al. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s409513 · Cited by 16
Ma, Y., Yang, H., Wang, X., Huang, Y., Li, Y., & Pan, G. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118968 · Cited by 20
Zhang, Y., Huang, Y., Fan, J., Zhang, M., Hasan, A., Yang, Y., Yu, R., Zhou, X., Ye, M., & Qiao, X. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c02086 · Cited by 14
Roessler, J., Zimmermann, F., Schumann, P., Nageswaran, V., Rad, P. R., Schuchardt, S., Leistner, D. M., Landmesser, U., & Haghikia, A. (2024) · Nutrients · doi:10.3390/nu16142368 · Cited by 16
“Moreover, the activation of bile acid receptors (TGR-5, FXR) on immune cells promotes an anti-inflammatory phenotype, marked by an increase in M2 macrophages and Treg cells in the gut mucosa, along with the upregulation of anti-inflammatory cytokines such as IL-10 [23].”
BackgroundResultLai, Y., Wu, X., Chao, E., Bloomstein, J. D., Wei, G., Hwang, S. T., & Shi, Z. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.05.012 · Cited by 13
Biagioli, M., Giorgio, C. D., Morretta, E., Bellini, R., Massa, C., Urbani, G., Bordoni, M., Marchianò, S., Lachi, G., Sepe, V., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107403 · Cited by 15
Self-citationWen, L., Yang, K., Wang, J., Zhou, H., & Ding, W. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1574887 · Cited by 15
“Erchen decoction (ECD) demonstrates notable ef fi cacy in lowering body mass and blood triglyceride concentrations; enhancing gut microbial diversity; and boosting the proportional presence of Lactobacillus , Bi fi dobacterium , and Butyricicoccu s; while diminishing the abundances of Bacteroides , Parabacteroides , and…”
InfluentialThe discovery of 12β-methyl-17-epi-18-nor-bile acids as potent and selective TGR5 agonists
Luxenburger, A., Harris, L. D., Ure, E. M., Jiao, W., Woolhouse, A. D., Cameron, S. A., Weymouth‐Wilson, A., Furneaux, R. H., Pitman, J. L., & Hinkley, S. F. R. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115143 · Cited by 14
Wang, G., Feng, X., Bu, Z., Tang, H., Xia, Y., Song, X., Wu, Y., & Ai, L. (2023) · iScience · doi:10.1016/j.isci.2023.106196 · Cited by 13
Bile Acids in Inflammatory Bowel Disease: From Pathophysiology to Treatment
Bai, S. H., Chandnani, A., & Cao, S. “. (2024) · Biomedicines · doi:10.3390/biomedicines12122910 · Cited by 19
Bioinspired and bioderived nanomedicine for inflammatory bowel disease
Gazzi, R. P., Gelli, R., Aleandri, S., Carone, M., & Luciani, P. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1986 · Cited by 14
Yu, X., Cao, T., Ipemba, E., Bakala, G. B., Leveut, L. G. D., Peng, W., Ji, F., Li, H., Xu, L., & Wu, H. (2025) · Poultry Science · doi:10.1016/j.psj.2025.105276 · Cited by 11
“Gut microbiota dysbiosis can also alter the composition of the bile acid pool, trigger immune activation, and promote inflammatory responses (Biagioli et al., 2021).”
The gut-liver axis modulates intestinal immune homeostasis
Gu, Y., & Wu, C. (2025) · Mucosal Immunology · doi:10.1016/j.mucimm.2025.12.001 · Cited by 15
Fiorillo, B., Roselli, R., Finamore, C., Biagioli, M., Giorgio, C. D., Bordoni, M., Conflitti, P., Marchianò, S., Bellini, R., Rapacciuolo, P., et al. (2023) · ACS Omega · doi:10.1021/acsomega.2c07907 · Cited by 12
Self-citationUehara, M., Inoue, T., Hase, S., Sasaki, E., Toyoda, A., & Sakakibara, Y. (2024) · mSystems · doi:10.1128/msystems.01405-23 · Cited by 10
“This module included the host gene CYP27A1 , which is involved in bile acid production (47), and NR1H3 , a host gene that codes for a bile acid receptor (48).”
BackgroundGao, Y., Yue, J., Ha, F., Wang, Y., Wang, R., Yang, X., Zhang, J., Liu, X., Zhang, Y., Han, T., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.97059 · Cited by 10
Zhang, Q., Xu, F., Wang, Z., Liu, S., Zhu, S., Zhang, S., & Wu, S. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16880 · Cited by 10
“In the gut–liver axis, bile acids played a vital role in regulating intestinal flora and innate immunity [23, 24].”
Fang, Q., Qin, C., Peng, Y., Zhang, L., Li, D., & Hu, S. (2025) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2025.104893 · Cited by 12
Zhao, Q., Hao, D., Wang, S., Chen, S., Zhou, C., Chen, F., Su, Q., Huang, W., Liu, J., Kong, Q., et al. (2025) · mSystems · doi:10.1128/msystems.01347-24 · Cited by 13
“Hypoxia stimulates the adrenal glands to secrete steroid hormones, increasing the levels of antiinflammatory hormones, which can mitigate tissue damage and inflammation induced by hypoxia to a certain extent (20).”
Causal Effects of Blood Lipid Traits on Inflammatory Bowel Diseases: A Mendelian Randomization Study
Yao, Z., Jiang, F., Luo, H., Zhou, J., Shi, W., Xu, S., Zhang, Y., Dai, F., Li, X., Liu, Z., et al. (2023) · Metabolites · doi:10.3390/metabo13060730 · Cited by 10
Natural Products on Inflammatory Bowel Disease: Role of Gut Microbes
Cheng, W.-W., Liu, B.-H., Hou, X.-T., Meng, H., Wang, D., Zhang, C.-H., Yuan, S., & Zhang, Q. (2024) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x24500514 · Cited by 12
Lane, J. M., Brosschot, T. P., Gatti, D. M., Gauthier, C. M., Lawrence, K. M., Pluzhnikova, V., & Reynolds, L. A. (2023) · Frontiers in Parasitology · doi:10.3389/fpara.2023.1214136 · Cited by 10
Cheng, Y., Wang, S., Zhu, W., Xu, Z., Xiao, L., Wu, J., Meng, Y., Zhang, J., & Cheng, C. (2024) · Scientific Reports · doi:10.1038/s41598-024-66660-3 · Cited by 9
“The gut microbiota could modify the BAs participate in extensive physiological regulation, and even trigger the immune responses and induce chronic inflammation 20 .”
BackgroundExploring the influence of gut microbiota metabolites on vitiligo through the gut-skin axis
Yuan, C., Liu, L., Zeng, D., Yuan, J., Guo, L., & Zhang, J. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1566267 · Cited by 8
“…(CAR)—as well as membrane receptors such as G-protein bile acid receptor 1 (GPBAR1 or TGR5), sphingosine-1-phosphate receptor 2 (S1PR2), muscarinic cholinergic receptors 2 and 3 (CHRM2 and CHRM3), and MAS-related G-protein-coupled receptor family member X4 (MRGPRX4) (Biagioli et al., 2021).”
Emerging mechanisms of microplastic-induced skin diseases: a perspective from the gut–skin axis
Zhang, X., Zheng, P., Yang, M., Huang, Y., Liu, E., Liu, A., Zhang, H., & Guo, J. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-025-07300-w · Cited by 11
“Additionally, they also modulate dendritic cell and macrophage polarization, maintaining immune homeostasis in both gut and skin [152].”
Aswinanand, B., Haridevamuthu, B., Guru, A., & Arockiaraj, J. (2025) · Antonie van Leeuwenhoek · doi:10.1007/s10482-025-02097-6 · Cited by 8
Zou, Q., Zhang, W., Xie, H., Ying, S., Zeng, X., Yao, Y., Zeng, D., Wang, J., Zhang, C., & Meng, F. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1745929 · Cited by 7
“Activated Th1 and Th17 cells secrete a variety of in fl ammatory cytokines, such as IL-17, IL-21, IL-22, TNF-a and IFN-g .”
InfluentialMolecular Ensembles of Microbiotic Metabolites in Carcinogenesis
Shatova, O. P., Zabolotneva, A. A., & Shestopalov, A. V. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923070027 · Cited by 9
Shen, L., Wang, C., Ren, R., Liu, X., Zhou, D., Chen, Y., Zhou, Y. J., Lei, J., Xiao, Y., Zhang, N., et al. (2024) · Inflammation Research · doi:10.1007/s00011-024-01910-8 · Cited by 9
“Increasing evidence suggests that disorders in BA metabolism play a role in the development of IBD [ 35, 36 ].”
Local and systemic features of ILC immunometabolism
Surace, L., & Santo, J. P. D. (2022) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000722 · Cited by 6
“, vitamins and flavonoids) [45,46], bile acids [47] and high-salt diet ([48]) boost NK cell proliferation and function, whereas increased lipid metabolism can impair NK cells antitumor activity [49 && ].”
BackgroundFan, G., Chen, W., He, J., Wang, D., & Yang, X. (2024) · Research in Veterinary Science · doi:10.1016/j.rvsc.2024.105526 · Cited by 5
Leng, S.-Y., Yang, Q., Yuan, Y., Chen, B., Chen, H., Ban, W., & Zhang, J. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1677896 · Cited by 6
Gut microbial bile salt hydrolase as a metabolic gatekeeper in digestive homeostasis and disease
Chu, H., Song, X., Liu, C., Ma, T., & Cui, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1870619 · Cited by 7
“In parallel, bile acid receptor signaling directly contributes to tight junction maintenance and epithelial repair (61, 62).”
Gagnon, W., Garneau, V., Trottier, J., Verreault, M., Couillard, C., Roy, D., Marette, A., Drouin‐Chartier, J., Vohl, M., & Barbier, O. (2022) · Nutrients · doi:10.3390/nu14183857 · Cited by 8
“BAs and their derivatives play major roles in the regulation of cholesterol and act as endogenous ligands for several nuclear and membrane receptors (namely the farnesoid X receptor (FXR), pregnane X receptor (PXR), vitamin D receptor (VDR), constitutive androstane receptor (CAR), and Takeda G protein-coupled receptor…”
BackgroundZhu, Y., Mei, Y., Baby, N., Teo, H. Y., Hanafi, Z. B., Salleh, S. N. M., Sajikumar, S., & Liu, H. (2023) · Communications Biology · doi:10.1038/s42003-023-05036-1 · Cited by 5
“On the other hand, some studies have shown that certain types of bile acids exhibited anti-in fl ammatory properties by activating farnesoid X receptor and G-protein-coupled bile acid receptor signaling pathways 42 .”
Microbial Translocation Disorders: Assigning an Etiology to Idiopathic Illnesses
Sfera, A., Hazan, S., Klein, C. A., del Campo, C. M. Z.-M., Sasannia, S., Anton, J. J., Rahman, L., Andronescu, C. V., Sfera, D. O., Kozlakidis, Z., et al. (2023) · Applied Microbiology · doi:10.3390/applmicrobiol3010015 · Cited by 7
“Maintaining an appropriate balance between the tolerogenic IL-22 and proinflammatory IL-17 is necessary for enabling GALT to distinguish between gut commensals and pathogens [66].”
BackgroundFinamore, C., Festa, C., Barbato, R., Fiorucci, S., Zampella, A., & Marino, S. D. (2025) · ChemMedChem · doi:10.1002/cmdc.202500405 · Cited by 5
Self-citationBiagioli, M., Giorgio, C. D., Marchianò, S., Sensini, B., Urbani, G., Giannelli, E., Lachi, G., Massa, C., Sette, M. R., Paniconi, F., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2645125 · Cited by 6
“20,59 To determine whether the beneficial effects exerted by 9-strains probiotic were mediated by the production of secondary bile acids and subsequent activation of GPBAR1, we conducted a chronic DSS-induced colitis protocol in both Gpbar1 +/+ and Gpbar1 −/− mice treated with 9-strains probiotic…”
Self-citationZabolotneva, A. A., Shatova, O. P., Shegai, P. V., & Shestopalov, A. V. (2023) · Oncology Advances · doi:10.14218/ona.2023.00014 · Cited by 3
Zhu, F., Ren, C., Zhou, K., Huang, X., Mei, M., Niu, H., & Ren, S. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70584 · Cited by 2
Peng, X., Ma, L., Huang, J., Long, W., Luo, Y., Wang, Y., & Liu, Y. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.115000 · Cited by 2
Jiang, L., Xue, T., Zhang, H., Zhang, Q., & Deng, H. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121250 · Cited by 2
Li, L., Yang, C., Wang, Z., Zhou, B., Zhang, Y., Liu, H. B., Sun, S., Chen, M., Hu, X., Jia, F., et al. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.04.011 · Cited by 5
Yang, Y., Ren, L., Zhang, Y., Wang, X., Shang, J., & Zhang, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1884030 · Cited by 2
Usefulness of colestimide for diarrhea in postoperative Crohn's disease
Hojo, A., Kobayashi, T., Matsubayashi, M., Morikubo, H., Miyatani, Y., Fukuda, T., Asonuma, K., Sagami, S., Nakano, M., Matsuda, T., et al. (2022) · JGH Open · doi:10.1002/jgh3.12786 · Cited by 2
Bile acid dysmetabolism in inflammatory bowel diseases
Kuznetsova, D. A., Lapin, S. V., & Владимировна, Г. И. (2023) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2023-51-007 · Cited by 3
Biagioli, M., Giorgio, C. D., Massa, C., Marchianò, S., Bellini, R., Bordoni, M., Urbani, G., Roselli, R., Lachi, G., Morretta, E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.08.588556 · Cited by 2
Self-citationRegulation of innate lymphoid cell by microbial metabolites
Tao, H., Geng, J., Bai, L., Su, D., Zhao, Y., Xu, G., & Zhang, M. (2025) · Journal of Molecular Medicine · doi:10.1007/s00109-025-02530-3 · Cited by 1
“In the immune cells, the primary bile acid receptors are the G protein-coupled bile acid receptor 1 (GPABR1 or TGR5), Farnesoid-X-recep-tor (FXR), and RORγt [82].”
Nuclear receptors as therapeutic targets in metabolic and cardiovascular disorders
Li, F., Chen, Q., Dai, Y., & Lu, L. (2025) · iScience · doi:10.1016/j.isci.2025.114042 · Cited by 1
Forcina, G., Frattolillo, V., Cesare, M. D., Floriano, A., Palma, R., Casamassima, F., Bartiromo, M., Marzuillo, P., del Giudice, E. M., & Sessa, A. D. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2600386 · Cited by 1
“Liver dysfunction may disrupt bile acid homeostasis, a key regulator of gut microbiota and innate immunity [145,146], promoting bacterial overgrowth and dysbiosis – factors associated with increased IBD risk [147].”
Schaal, T., Akbarimoghaddam, P., Wegner, V. D., Steube, A., Gardey, E., Feile, A., Hassan, M. I. A., Cseresnyés, Z., Stallmach, A., Mosig, A. S., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2701400 · Cited by 2
“6 These metabolic changes may promote immune cell activation and differentiation, thereby contributing to chronic intestinal inflammation.”
Regulation of Immune Cell Functions by Bile Acid-Activated ReceptorsPreprint
Cheung, K. C. P., Jiao, M. A., Loiola, R. A., Chen, X., & Jia, W. P. (2022) · doi:10.22541/au.166899605.52123374/v1
Molecular orchestra of microbiotic metabolites in the scenario of carcinogenesis
Shatova, O. P., Zabolotneva, A. A., & Shestopalov, A. V. (2023) · Biochemistry (Moscow) · doi:10.31857/s0320972523070023
Kucherova, N. Y., & Tarasova, L. V. (2025) · Koloproktologia · doi:10.33878/2073-7556-2025-24-3-115-127
Yu, D., Tian, Q., Shen, J., Fang, L., Tan, Z., & Cai, Y. (2025) · Experimental Biology and Medicine · doi:10.3389/ebm.2025.10725
Introduction: NanoBioMedicine and its promise in gastrointestinal diseases
Singh, A. K., Malviya, H., Chaturvedi, V. K., Singh, A. K., Yadav, D. P., & Singh, J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-34039-0.00007-x
Gu, Y., Wang, H., Bao, Y., Zhao, W., Zhu, T., Sun, P., Zhou, Q., & Jin, M. (2025) · Aquaculture Reports · doi:10.1016/j.aqrep.2025.103231
Chen, X., Chen, C., Lan, X., Zhang, X., Li, T., Zhang, P., Cheng, G., Zhou, W., 王章星, Xie, Y., et al. (2026) · mSystems · doi:10.1128/msystems.01405-25 · Cited by 2
“Bile acids act as important immunomodulators that regulate a range of immune cell functions by activating receptors such as TGR5 and FXR (62, 63).”
Regulation of Gut Microflora by Tea
Hu, S. (2026) · Springer eBooks · doi:10.1007/978-3-032-11828-8_11
Huang, Z., Ren, J., Shu, Q., Tang, Y., Zhang, J., Yu, W., Zhang, C., Pang, Y., Liu, L., Han, J., et al. (2026) · Biology · doi:10.3390/biology15070558
“These molecules are potent ligands for the Vitamin D Receptor (VDR), the Farnesoid X Receptor (FXR), and modulators of the orphan receptor NR4A1 (Nur77) [82].”
Giorgio, C. D., Biagioli, M., Marchianò, S., Massa, C., Lachi, G., Urbani, G., Bordoni, M., Bellini, R., Cari, L., Sensini, B., et al. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102653
“Additionally, FXR activation in NKT cells has been shown to suppress the production of inflammatory cytokines, further highlighting the complex role of FXR in immune regulation within the cancer microenvironment [13].”
Self-citationYang, H., Zhang, X., Zhou, D., Zou, J., Xu, L., Chen, M., Zhao, S., Dai, J., Wang, X., Du, X., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118225 · Cited by 1
Microbiota and lipid mediators: from molecular crosstalk to therapeutic opportunities
Gökcen, B. B., Atabılen, B., Güneş, B. D., Dazıroğlu, M. E. Ç., Özer, Ş. D., Biten, A. A., Pagano, E., Nanì, M. F., Romano, B., Ağagündüz, D., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1836931
“These oxo-derivatives of BAs can function as inverse agonists for ROR γ t, thus directly reducing inflammation, especially on Th17 cells (Biagioli et al., 2021).”
Bile acids as mediators of microbiota signaling in entero-hepatic disorders
Fiorucci, S., Marchianò, S., Giorgio, C. D., Urbani, G., Monti, M. C., Zampella, A., Distrutti, E., & Biagioli, M. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118341 · Cited by 1
Self-citationLi, J., He, Y., Wang, J., Sun, Y., Zhang, L., Liu, L., Li, C., Zhang, G., & Du, P. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109776 · Cited by 1
Decoding the Biological Function of Bile Acids for Drug Discovery
Yang, J., & Lei, X. (2026) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6c00477
Kiss, G., Mózes, B., Sterczer, Á., Lányi, K., Németh, K., & Psáder, R. (2026) · Animals · doi:10.3390/ani16182887
“FXR regulates BA synthesis, transport, epithelial barrier function, and metabolic pathways, whereas TGR5 activation by secondary BAs can modulate macrophage and enteroendocrine signaling, gastrointestinal motility, and inflammatory responses [9,18,24–28].”
InfluentialBile acid signaling in health and disease
Fan, Z., He, M., Liang, T., 张必利, Zhao, N., & Li, P. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00603-4
“Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), results from genetic, environmental, microbial, and immune factors, with disrupted BA homeostasis serving as a key amplifying factor [14, 190–192].”
Dong, J., & Zhou, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1948343
He, R., ZHENG, Q., & Shen, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1910940
Metadata
- Authors
- Biagioli, M., Marchianò, S., Carino, A., Di Giorgio, C., Santucci, L., Distrutti, E., & Fiorucci, S.
- Affiliations
- University of Perugia (IT)
- Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy
- Azienda Ospedaliera di Perugia (IT)
- Corresponding author
- Biagioli, Michele
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2021-05-21
- Volume
- 10
- Issue
- 6
- Pages
- 1281
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC8224328
- OpenAlex
- W3162040744
- Cited by
- 103
- References
- 108
- Citations by year
- 2026: 23 · 2025: 21 · 2024: 21 · 2023: 23 · 2022: 15
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- bile acids, bile acid receptors, inflammatory bowel disease, TGR5, farnesoid X receptor, RORγt, gut microbiota, dysbiosis, intestinal inflammation, innate lymphoid cells, Th17 cells, dendritic cells, macrophages, secondary bile acids, host-microbe communication
- MeSH terms
- Gastrointestinal Microbiome, Receptor, Farnesoid X-Activated, Animals, Bile Acids and Salts, Humans, Immunity, Innate, Inflammatory Bowel Diseases, Receptors, Cytoplasmic and Nuclear, Receptors, G-Protein-Coupled
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.